No abstract available
Keywords:
Actemra; Rituxan; Yescarta; adverse effects; axicabtagene ciloleucel; corticosteroids; cyclophosphamide; dosage; doxorubicin; efficacy; lymphoma; prednisone; pregnancy; rituximab; safety; tisagenlecleucel; tocilizumab; vincristine.
MeSH terms
-
Antigens, CD19 / immunology
-
Antigens, CD19 / therapeutic use*
-
Biological Products
-
Disease-Free Survival
-
Drug Approval
-
Humans
-
Immunotherapy, Adoptive
-
Lymphoma, B-Cell / drug therapy*
-
Receptors, Antigen, T-Cell / immunology
-
T-Lymphocytes / immunology*
-
United States
-
United States Food and Drug Administration
Substances
-
Antigens, CD19
-
Biological Products
-
Receptors, Antigen, T-Cell
-
axicabtagene ciloleucel